Keyphrases
Oligometastatic Prostate Cancer
100%
Radiotherapy
22%
Focal Therapy
22%
Imaging Modalities
11%
Docetaxel
11%
Clinical Trials
11%
Prostate
11%
Prostate Radiotherapy
11%
Disease Biology
11%
Systemic Therapy
11%
Participation in Clinical Trials
11%
Androgen Deprivation Therapy
11%
Metastatic Disease
11%
Abiraterone
11%
Primary Tumor
11%
Resection
11%
Disease Spectrum
11%
Overall Survival
11%
Patient Selection
11%
Failure-free Survival
11%
Biochemical Recurrence
11%
Survival Benefit
11%
Distant Metastasis
11%
Conventional Imaging
11%
Metastatic Site
11%
Multimodality Approach
11%
Institutional Registry
11%
Clinical Trial Registry
11%
Low Volume Disease
11%
Polymetastatic Disease
11%
Combined Modality Therapy
11%
Clinical Behavior
11%
Collaborative Efforts
11%
Transitional State
11%
Medicine and Dentistry
Prostate Cancer
100%
Disease
33%
Clinical Trial
22%
Radiation Therapy
22%
Retrospective Study
22%
Cancer Therapy
11%
Metastatic Carcinoma
11%
Prevalence
11%
Androgen Deprivation Therapy
11%
Primary Tumor
11%
Systemic Therapy
11%
Overall Survival
11%
Failure Free Survival
11%
Biochemical Recurrence
11%
Conventional Imaging
11%
Abiraterone
11%
Surgery
11%
Docetaxel
11%